Our server located the best source for… detailed information.
 

We also recommend that you use our engine focused on research literature.    [About My Drug Index]

                                                                   

Relevant keywords from our medical encyclopedia…

respiratory syncytial virus immune globulin intravenous, res-pi-ra-tor-e sin-sish-al vi-ras im-mune glob-yoo-lin in-tra-ve-nas, rsv-igiv, belongs to a group, medicines known as immunizing agents, rsv-igiv, prevent infection caused by respiratory syncytial virus, rsv, rsv-igiv works by giving my body the antibodies it needs to protect it against rsv infection, rsv infection can cause serious problems, pneumonia and bronchitis, which affect the lungs; and in severe cases, even death, problems are more likely to occur in infants and young children less than 6 months, age with chronic lung disease, those born with heart problems, those with a history, premature birth, onset, rsv activity usually occurs in november and continues through april, early may, with peak activity occurring from late january through mid-february, a good way to help prevent rsv infection is to get rsv-igiv before the start, the rsv season, rsv-igiv, prevent serious lower respiratory tract infection caused by the respiratory syncytial virus, rsv, in children less than 24 months, age with breathing problems, a history, premature birth, rsv-igiv is, administered only by, under the supervision, other health care professional, available, following dosage form parenteral, injection, for respiratory syncytial virus immune globulin intravenous, rsv-igiv, allergic reaction to intramuscular, intravenous immune globulins, allergic to any other substances, foods, preservatives, dyes, studies on effects in pregnancy, haven't been done in either humans, animals, when breast-feeding , not known whether rsv-igiv passes into breast milk, has not been reported to cause problems in nursing babies, children children 24 months, age and older: use is not recommended, use is not recommended in children born with chronic heart disease , too much fluid, body is more likely to occur in infants and children with underlying lung disease, rsv-igiv has been tested only in infants and young children less than 24 months, age and there is no specific information about its use in older patients, an interaction might occur, change the dose, using any other prescription, nonprescription, over-the-counter, otc, other medical problems, rsv-igiv, any other medical problems, allergic reaction to human immunoglobulins, immunoglobulin a, iga, deficiencies, rsv-igiv, severe reactions, on any special diet, low-sodium, low-sugar diet, respiratory syncytial virus immune globulin intravenous, rsv-igiv, will be different for different patients, doses are based on body weight, the average doses, rsv-igiv, for injection, dosage form, for preventing respiratory syncytial virus, rsv, infection, adults and children 24 months, age and older, use is not recommended, infants and children younger than 24 months, 750 milligrams, per kilogram, 340.9 mg per pound, body weight injected into a vein once a month for five months, side effects, along with its needed effects, some unwanted effects, side effects may occur, may need medical attention, get emergency help immediately if, side effects occur, difficulty in breathing and swallowing, hives, itching, feet and hands, reddening, skin, especially around ears, swelling, eyes, face, inside, nose, unusual tiredness , weakness, sudden and severe, fever, 39.2 °c, 102.6 °f, higher, increased heart rate, vomiting, other side effects, brand names, respigam, respigam, another commonly used name is rsv-igiv, category immunizing agent, passive,